Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up.
Coralie AmadouSylvia FrancPierre-Yves BenhamouSandrine LablancheErik HunekerGuillaume CharpentierAlfred Penfornisnull nullPublished in: Diabetes care (2021)
The ability of the DBLG1 system to significantly improve glycemic control in real-world conditions, without serious adverse events, was confirmed in this follow-up study.